Novel Treatment Strategy Using Second-Generation Androgen Receptor Inhibitors for Non-Metastatic Castration-Resistant Prostate Cancer

Non-metastatic castration-resistant prostate cancer (nmCRPC) is defined by a progressively rising prostate-specific antigen level, despite a castrate level of testosterone, in the absence of obvious radiologic evidence of metastatic disease on conventional imaging modalities. As a significant propor...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Doo Yong, Ha, Jee Soo, Cho, Kang Su
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229358/
https://www.ncbi.nlm.nih.gov/pubmed/34207755
http://dx.doi.org/10.3390/biomedicines9060661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229358/
https://www.ncbi.nlm.nih.gov/pubmed/34207755
http://dx.doi.org/10.3390/biomedicines9060661

Ejemplares similares